Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients
Author(s) -
Shariq I. Sherwani,
Haseeb A. Khan,
Aishah Ekhzaimy,
Afshan Masood,
Meena Kishore Sakharkar
Publication year - 2016
Publication title -
biomarker insights
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.075
H-Index - 31
ISSN - 1177-2719
DOI - 10.4137/bmi.s38440
Subject(s) - medicine , diabetes mellitus , glycemic , glycated hemoglobin , disease , intensive care medicine , biomarker , stroke (engine) , risk factor , type 2 diabetes , endocrinology , mechanical engineering , biochemistry , chemistry , engineering
Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycemic control with the ability to reflect the cumulative glycemic history of the preceding two to three months. HbA1c not only provides a reliable measure of chronic hyperglycemia but also correlates well with the risk of long-term diabetes complications. Elevated HbA1c has also been regarded as an independent risk factor for coronary heart disease and stroke in subjects with or without diabetes. The valuable information provided by a single HbA1c test has rendered it as a reliable biomarker for the diagnosis and prognosis of diabetes. This review highlights the role of HbA1c in diagnosis and prognosis of diabetes patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom